02632nas a2200217   4500008004100000245012200041210006900163260001200232520184800244653004002092653003502132653004402167653001702211100002102228700002102249700001702270700002102287700002102308700002102329856006402350       2019                        eng d00aAn exploration of BCI performance variations in people with amyotrophic lateral sclerosis using longitudinal EEG data0 aexploration of BCI performance variations in people with amyotro  c05/20193 aObjective. Brain-computer interface (BCI) technology enables people to use direct measures of brain activity for communication and control. The National Center for Adaptive Neurotechnologies (NCAN) and Helen Hayes Hospital are studying long-term independent home use of P300-based BCIs by people with amyotrophic lateral sclerosis (ALS). This BCI use takes place without technical oversight, and users can encounter substantial variation in their day-to-day BCI performance. The purpose of this study is to identify and evaluate features in the electroencephalogram (EEG) that correlate with successful BCI performance during home use with the goal of improving BCI for people with neuromuscular disorders. Approach. Nine people with ALS used a P300-based BCI at home over several months for communication and computer control. Sessions from a routine calibration task were categorized as successful (≥70%) or unsuccessful (<70%) BCI performance. The correlation of temporal and spectral EEG features with BCI performance was then evaluated. Main Results. BCI performance was positively correlated with an increase in alpha-band (8-14 Hz) activity at locations PO8, P3, Pz, and P4; and beta-band (15-30 Hz) activity at occipital locations. In addition, performance was significantly positively correlated with a positive deflection in EEG amplitude around 220 ms at frontal mid-line locations (i.e., Fz and Cz). BCI performance was negatively correlated with delta-band (1-3 Hz) activity recorded from occipital locations. Significance. These results highlight the variability found in the EEG and describe EEG features that correlate with successful BCI performance during day-to-day use of a P300-based BCI by people with ALS. These results should inform studies focused on improved BCI reliability for people with neuromuscular disorders.10aamyotrophic lateral sclerosis (ALS)10aBrain-computer interface (BCI)10aLongitudinal Electroencephalogram (EEG)10aP300 speller1 aShahriari, Yalda1 aVaughan, Theresa1 aMcCane, Lynn1 aAllison, Brendan1 aWolpaw, Jonathan1 aKrusienski, Dean  uhttps://iopscience.iop.org/article/10.1088/1741-2552/ab22ea03835nas a2200301   4500008004100000022001400041245015300055210006900208260001200277520274700289653005303036653004003089653003503129653003403164653003303198653003503231100002003266700002203286700002603308700002103334700001903355700002103374700001903395700002603414700002103440700002403461856004803485       2015                        eng d  a1872-895200aP300-based brain-computer interface (BCI) event-related potentials (ERPs): People with amyotrophic lateral sclerosis (ALS) vs. age-matched controls.0 aP300based braincomputer interface BCI eventrelated potentials ER  c02/20153 a<p><b>OBJECTIVE: </b>Brain-computer interfaces (BCIs) aimed at restoring communication to people with severe neuromuscular disabilities often use event-related potentials (ERPs) in scalp-recorded EEG activity. Up to the present, most research and development in this area has been done in the laboratory with young healthy control subjects. In order to facilitate the development of BCI most useful to people with disabilities, the present study set out to: (1) determine whether people with amyotrophic lateral sclerosis (ALS) and healthy, age-matched volunteers (HVs) differ in the speed and accuracy of their ERP-based BCI use; (2) compare the ERP characteristics of these two groups; and (3) identify ERP-related factors that might enable improvement in BCI performance for people with disabilities.</p><p><b>METHODS: </b>Sixteen EEG channels were recorded while people with ALS or healthy age-matched volunteers (HVs) used a P300-based BCI. The subjects with ALS had little or no remaining useful motor control (mean ALS Functional Rating Scale-Revised 9.4 (±9.5SD) (range 0-25)). Each subject attended to a target item as the items in a 6×6 visual matrix flashed. The BCI used a stepwise linear discriminant function (SWLDA) to determine the item the user wished to select (i.e., the target item). Offline analyses assessed the latencies, amplitudes, and locations of ERPs to the target and non-target items for people with ALS and age-matched control subjects.</p><p><b>RESULTS: </b>BCI accuracy and communication rate did not differ significantly between ALS users and HVs. Although ERP morphology was similar for the two groups, their target ERPs differed significantly in the location and amplitude of the late positivity (P300), the amplitude of the early negativity (N200), and the latency of the late negativity (LN).</p><p><b>CONCLUSIONS: </b>The differences in target ERP components between people with ALS and age-matched HVs are consistent with the growing recognition that ALS may affect cortical function. The development of BCIs for use by this population may begin with studies in HVs but also needs to include studies in people with ALS. Their differences in ERP components may affect the selection of electrode montages, and might also affect the selection of presentation parameters (e.g., matrix design, stimulation rate).</p><p><b>SIGNIFICANCE: </b>P300-based BCI performance in people severely disabled by ALS is similar to that of age-matched control subjects. At the same time, their ERP components differ to some degree from those of controls. Attention to these differences could contribute to the development of BCIs useful to those with ALS and possibly to others with severe neuromuscular disabilities.</p>10aalternative and augmentative communication (AAC)10aamyotrophic lateral sclerosis (ALS)10aBrain-computer interface (BCI)10abrain-machine interface (BMI)10aelectroencephalography (EEG)10aevent-related potentials (ERP)1 aMcCane, Lynn, M1 aHeckman, Susan, M1 aMcFarland, Dennis, J.1 aTownsend, George1 aMak, Joseph, N1 aSellers, Eric, W1 aZeitlin, Debra1 aTenteromano, Laura, M1 aWolpaw, Jonathan1 aVaughan, Theresa, M  uhttp://www.ncbi.nlm.nih.gov/pubmed/25703940